Loading…
Loading…
EQUITY / NASDAQ · XNCM
Park Ha Biological Technology Co., Ltd.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →11/01/2024 – 10/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗2.35 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 2.35 USD · Volume 7,756
681 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
11/01/2024 – 10/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 2,524,843 USD | 2,381,851 USD | +6.00% |
| Operating profit | -24,148,901 USD | 793,714 USD | -3,142.52% |
| Net income | -24,364,753 USD | 478,561 USD | -5,191.25% |
| Operating cash flow | 85,852 USD | 960,470 USD | -91.06% |
| Cash and cash equivalents | 3,787,678 USD | 547,498 USD | +591.82% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end11/01/2024 – 10/31/2025ConsolidatedUnits · USD | 2024 / Year end11/01/2023 – 10/31/2024ConsolidatedUnits · USD | 2023 / Year end11/01/2022 – 10/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Capital expendituresCash flow statement | 88,825 USD | 85,569 USD | 22,676 USD |
| Cash and cash equivalentsBalance sheet | 3,787,678 USD | 547,498 USD | — |
| Financing cash flowCash flow statement | 3,735,677 USD | -957,389 USD | -676,925 USD |
| Gross profitIncome statement | 2,382,317 USD | 2,186,515 USD | 2,148,113 USD |
| Investing cash flowCash flow statement | -572,927 USD | -508,143 USD | 1,023,419 USD |
| Net incomeIncome statement | -24,364,753 USD | 478,561 USD | 852,042 USD |
| Operating cash flowCash flow statement | 85,852 USD | 960,470 USD | 126,537 USD |
| Operating profitIncome statement | -24,148,901 USD | 793,714 USD | 1,180,554 USD |
| RevenueIncome statement | 2,524,843 USD | 2,381,851 USD | 2,459,102 USD |
| Total assetsBalance sheet | 5,952,616 USD | 3,083,283 USD | — |
| Total equityBalance sheet | 3,994,855 USD | 1,506,085 USD | 1,012,473 USD |
| Total liabilitiesBalance sheet | 1,957,761 USD | 1,577,198 USD | — |
| Report source | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 05/15/2026 | Open report ↗ Published: 05/15/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.